David Francis Carroll

David Francis Carroll, listed as finance chief, appears in our data through filings on IVERIC bio, Inc. shares, published by SEC (Form 4). Between 9 December 2021 and 11 July 2023, the trades on record add up to 15 filings.

The open-market record consists of 2 sales worth €829k, with no purchase. Other entries cover 11 option exercises.

Most recently, on 13 July 2023, the filings show a transaction in IVERIC bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.